Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Apr 22, 2024

BUY
$96.41 - $126.61 $26,705 - $35,070
277 Added 25.51%
1,363 $140,000
Q3 2023

Oct 23, 2023

BUY
$96.41 - $126.61 $26,705 - $35,070
277 Added 25.51%
1,363 $140,000
Q2 2023

Apr 22, 2024

SELL
$118.5 - $160.53 $53,325 - $72,238
-450 Reduced 29.3%
1,086 $131,000
Q2 2023

Aug 11, 2023

SELL
$118.5 - $160.53 $53,325 - $72,238
-450 Reduced 29.3%
1,086 $131,000
Q1 2023

Apr 22, 2024

BUY
$135.66 - $197.02 $208,373 - $302,622
1,536 New
1,536 $235,000
Q1 2023

May 11, 2023

SELL
$135.66 - $197.02 $54,264 - $78,808
-400 Reduced 20.66%
1,536 $235,000
Q4 2022

Feb 13, 2023

SELL
$118.38 - $210.04 $53,271 - $94,518
-450 Reduced 18.86%
1,936 $347,000
Q3 2022

Nov 14, 2022

BUY
$118.07 - $194.18 $147,587 - $242,725
1,250 Added 110.04%
2,386 $282,000
Q2 2022

Aug 11, 2022

SELL
$117.13 - $176.59 $7,496 - $11,301
-64 Reduced 5.33%
1,136 $162,000
Q1 2022

Apr 25, 2022

BUY
$126.46 - $235.05 $52,354 - $97,310
414 Added 52.67%
1,200 $207,000
Q4 2021

Feb 14, 2022

SELL
$225.82 - $368.51 $3.84 Million - $6.27 Million
-17,009 Reduced 95.58%
786 $200,000
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $1.09 Million - $2.38 Million
4,903 Added 38.03%
17,795 $6.85 Million
Q2 2021

Nov 12, 2021

BUY
$129.91 - $234.98 $1.65 Million - $2.98 Million
12,672 Added 5760.0%
12,892 $3.03 Million
Q1 2021

Nov 12, 2021

BUY
$109.18 - $185.98 $21,836 - $37,196
200 Added 1000.0%
220 $29,000
Q4 2020

Jan 22, 2021

SELL
$65.74 - $169.86 $1,314 - $3,397
-20 Reduced 50.0%
20 $2,000
Q2 2020

Jul 10, 2020

BUY
$29.67 - $80.0 $1,186 - $3,200
40 New
40 $3,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Hoey Investments, Inc Portfolio

Follow Hoey Investments, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hoey Investments, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hoey Investments, Inc with notifications on news.